(NASDAQ: QTTB) Q32 Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 68.7%.
Q32 Bio's earnings in 2026 is $33,243,000.On average, 7 Wall Street analysts forecast QTTB's earnings for 2026 to be -$31,408,368, with the lowest QTTB earnings forecast at -$36,558,031, and the highest QTTB earnings forecast at -$22,077,252. On average, 7 Wall Street analysts forecast QTTB's earnings for 2027 to be -$38,569,062, with the lowest QTTB earnings forecast at -$46,528,403, and the highest QTTB earnings forecast at -$30,089,158.
In 2028, QTTB is forecast to generate -$37,738,197 in earnings, with the lowest earnings forecast at -$51,181,243 and the highest earnings forecast at -$28,130,692.